Max India Ltd(Merged)
Max India is primarily engaged in making business investment in its subsidiaries and providing management advisory services to the group companies.(Source : 201903 Annual Report Page No: 158)
- Market Cap ₹ 2,029 Cr.
- Current Price ₹ 63.6
- High / Low ₹ /
- Stock P/E 5.66
- Book Value ₹ 39.2
- Dividend Yield 0.00 %
- ROCE -2.49 %
- ROE -3.68 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
Cons
- Company has a low return on equity of -4.68% over last 3 years.
- Earnings include an other income of Rs.415 Cr.
- Debtor days have increased from 39.6 to 61.3 days.
- Working capital days have increased from 723 days to 2,697 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 15m | Mar 2017 | Mar 2018 | Mar 2019 | TTM | |
|---|---|---|---|---|---|
| 1,220 | 1,428 | 242 | 157 | 150 | |
| 1,223 | 1,393 | 323 | 207 | 283 | |
| Operating Profit | -3 | 35 | -80 | -50 | -133 |
| OPM % | -0% | 2% | -33% | -32% | -89% |
| 11 | 28 | 85 | -49 | 415 | |
| Interest | 41 | 53 | 26 | 24 | 23 |
| Depreciation | 56 | 53 | 4 | 5 | 7 |
| Profit before tax | -88 | -43 | -26 | -128 | 252 |
| Tax % | 12% | 8% | 28% | 2% | |
| -99 | -46 | -33 | -131 | 250 | |
| EPS in Rs | -2,691.67 | -1.73 | -1.58 | -3.21 | 11.51 |
| Dividend Payout % | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -50% |
| TTM: | -35% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 13% |
| TTM: | 39% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -5% |
| Last Year: | -4% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | |
|---|---|---|---|---|
| Equity Capital | 0.05 | 53 | 54 | 54 |
| Reserves | 1,152 | 1,214 | 1,236 | 1,116 |
| 524 | 654 | 214 | 194 | |
| 773 | 993 | 846 | 971 | |
| Total Liabilities | 2,449 | 2,914 | 2,349 | 2,335 |
| 936 | 931 | 170 | 120 | |
| CWIP | 248 | 444 | 4 | 6 |
| Investments | 738 | 953 | 1,631 | 821 |
| 527 | 587 | 544 | 1,388 | |
| Total Assets | 2,449 | 2,914 | 2,349 | 2,335 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | |
|---|---|---|---|---|
| 31 | -3 | |||
| -54 | 13 | |||
| 25 | -16 | |||
| Net Cash Flow | 2 | -5 | ||
| Free Cash Flow | 4 | 7 | ||
| CFO/OP | -60% | -19% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | |
|---|---|---|---|---|
| Debtor Days | 34 | 33 | 24 | 61 |
| Inventory Days | 22 | 20 | 829 | 2,053 |
| Days Payable | 406 | 458 | 342 | 166 |
| Cash Conversion Cycle | -351 | -404 | 511 | 1,948 |
| Working Capital Days | -119 | -114 | -414 | 2,697 |
| ROCE % | 0% | -2% | -2% |
Insights
In beta| Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| ALOS (Average Length of Stay) Days |
|
|||||||||
| ARPOB (Average Revenue Per Occupied Bed Day) INR |
||||||||||
| Average Inpatient Occupancy % |
||||||||||
| Number of Hospitals Number |
||||||||||
| Operational Beds (MHC Network) Number |
||||||||||
| OPD Footfalls Million |
||||||||||
| Antara Dehradun Cumulative Sales Units |
||||||||||
Documents
Announcements
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. 11 Nov 2020
- Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011. 3 Oct 2020
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. 1 Oct 2020
- Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011. 29 Sep 2020
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. 29 Sep 2020
Annual reports
Concalls
-
Feb 2020Transcript PPT
-
Nov 2019Transcript PPT
-
Aug 2019TranscriptAI SummaryPPT
-
May 2019TranscriptAI SummaryPPT
-
Feb 2019TranscriptAI SummaryPPT
-
Nov 2018TranscriptAI SummaryPPT
-
Aug 2018TranscriptAI SummaryPPT
-
May 2018TranscriptAI SummaryPPT
-
Feb 2018TranscriptAI SummaryPPT
-
Feb 2018Transcript PPT
-
Nov 2017TranscriptAI SummaryPPT
-
Aug 2017Transcript PPT
-
May 2017TranscriptPPT
-
Feb 2017TranscriptPPT
-
Nov 2016TranscriptPPT